Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Haematologica - 1 May 2010

te Winkel Mariël L, van Beek Robert D, de Muinck Keizer-Schrama Sabine M P F, Uitterlinden André G, Hop Wim C J, Pieters Rob, van den Heuvel-Eibrink Marry M

Abstract excerpt

BACKGROUND: This study investigates pharmacogenetic risk factors for bone mineral (apparent) density (BM(A)D) and body composition in pediatric acute lymphoblastic leukemia DESIGN AND METHODS: We determined the influence of SNPs in 4 genes (vitamin-D receptor (VDR: BsmI/ApaI/TaqI and Cdx-2/GATA),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Composition
Share to Bone Density
Share to Collagen Type I, alpha 1 Chain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dexamethasone

Share to Estrogen Receptor alpha

Share to Follow-Up Studies

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Receptors, Calcitriol

Source

Open in PubMed Open full text

Identifiers

PMID: 20015871
DOI: 10.3324/haematol.2009.016303
PMCID: PMC2864381

Genes

VDR
ESR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20015871-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.PMID 20015871Read ↗

Bone mineral density in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.Semantic proximity Read ↗

Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.Semantic proximity Read ↗

Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density.Semantic proximity Read ↗

CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.Semantic proximity Read ↗

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalitiesSemantic proximity Read ↗

A Genomewide Association Study Identifies Two Sex‐Specific Loci, at SPTB and IZUMO3, Influencing Pediatric Bone Mineral Density at Multiple Skeletal SitesSemantic proximity Read ↗

Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.Semantic proximity Read ↗

Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.Semantic proximity Read ↗

Modifiable Factors Associated With Aging Phenotypes Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Gene polymorphisms, bone mineral density and bone mineral content in young children: the Iowa Bone Development Study.Semantic proximity Read ↗

A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.